Total Payments
$6,872
2024 Payments
$1,200
Companies
32
Transactions
399
Medicare Patients
1,694
Medicare Billing
$175,013
Payment Breakdown by Category
Food & Beverage$6,872 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,872 | 395 | 100.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$6,872
395 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,164 | 174 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $565.59 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $335.72 | 19 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $333.03 | 18 | $0 (2023) |
| GENZYME CORPORATION | $281.31 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $247.28 | 14 | $0 (2022) |
| Celgene Corporation | $216.69 | 40 | $0 (2024) |
| Amgen Inc. | $216.29 | 9 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $209.10 | 10 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $173.63 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,200 | 64 | ABBVIE INC. ($606.92) |
| 2023 | $1,502 | 104 | ABBVIE INC. ($632.96) |
| 2022 | $1,468 | 78 | ABBVIE INC. ($601.33) |
| 2021 | $1,546 | 87 | AbbVie Inc. ($852.21) |
| 2020 | $846.69 | 49 | AbbVie Inc. ($348.23) |
| 2019 | $294.91 | 16 | AbbVie, Inc. ($122.14) |
| 2018 | $13.66 | 1 | Ferring Pharmaceuticals Inc. ($13.66) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: VIROLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Immunology | ||||||
| 12/03/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: VIROLOGY | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Immunology | ||||||
| 10/02/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: LIVER DISEASE | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: VIROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Gastroenterology | ||||||
| 09/09/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: VIROLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 424 | 460 | $248,439 | $44,371 |
| 2022 | 9 | 391 | 430 | $219,195 | $40,764 |
| 2021 | 11 | 529 | 605 | $279,677 | $55,934 |
| 2020 | 11 | 350 | 396 | $177,554 | $33,944 |
Total Patients
1,694
Total Services
1,891
Medicare Billing
$175,013
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 74 | 75 | $80,025 | $14,453 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $19,958 | $6,732 | 33.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 82 | 86 | $58,480 | $4,601 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 53 | $11,501 | $4,408 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 54 | $7,992 | $3,400 | 42.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $28,798 | $3,013 | 10.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 24 | 25 | $16,225 | $2,383 | 14.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 13 | 22 | $12,386 | $2,167 | 17.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,726 | $1,693 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 16 | $2,336 | $972.82 | 41.6% |
| 43450 | Dilation of esophagus | Facility | 2023 | 18 | 18 | $6,012 | $549.20 | 9.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 67 | $71,489 | $12,893 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 84 | $18,228 | $7,262 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $19,588 | $6,433 | 32.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 77 | 82 | $54,068 | $5,934 | 11.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 42 | 44 | $37,268 | $3,829 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 44 | $6,512 | $2,486 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,066 | $847.02 | 27.6% |
| 43450 | Dilation of esophagus | Facility | 2022 | 23 | 24 | $8,016 | $727.46 | 9.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 12 | $960.00 | $352.08 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 100 | 100 | $30,056 | $12,336 | 41.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 46 | 46 | $58,322 | $9,090 | 15.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 71 | $15,120 | $6,547 | 43.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 89 | 91 | $68,802 | $6,325 | 9.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 54 | 60 | $17,853 | $6,199 | 34.7% |
About Paul Paradiso
Paul Paradiso is a Internal Medicine healthcare provider based in Rockwall, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1861836108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Paradiso has received a total of $6,872 in payments from pharmaceutical and medical device companies, with $1,200 received in 2024. These payments were reported across 399 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,872).
As a Medicare-enrolled provider, Paradiso has provided services to 1,694 Medicare beneficiaries, totaling 1,891 services with total Medicare billing of $175,013. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Rockwall, TX
- Active Since 04/17/2013
- Last Updated 09/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861836108
Products in Payments
- HUMIRA (Biological) $735.49
- LINZESS (Drug) $550.23
- RINVOQ (Biological) $483.99
- CREON (Drug) $419.14
- DUPIXENT (Biological) $412.10
- SKYRIZI (Biological) $385.09
- MAVYRET (Drug) $340.82
- ENTYVIO (Biological) $293.87
- STELARA (Biological) $286.42
- ZEPOSIA (Drug) $224.28
- CLENPIQ (Drug) $199.66
- OCALIVA (Drug) $197.68
- AVSOLA (Biological) $192.40
- Linzess (Drug) $173.63
- TRULANCE (Drug) $147.07
- MOTEGRITY (Drug) $136.82
- VIBERZI (Drug) $134.25
- CIMZIA (Drug) $133.37
- INJECTAFER (Drug) $117.95
- QSYMIA (Drug) $111.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rockwall
Carlos Arauz Pacheco, Md, MD
Internal Medicine — Payments: $481,717
Internal Medicine $481,717
Dr. Maria Viqar-Syed, Md, MD
Internal Medicine — Payments: $18,651
Internal Medicine $18,651
Dr. Delano Fabro, D.o, D.O
Internal Medicine — Payments: $11,136
Internal Medicine $11,136
Dr. Nicole Conselman, M.d, M.D
Internal Medicine — Payments: $7,940
Internal Medicine $7,940
Dr. Emily Mccullar, M.d, M.D
Internal Medicine — Payments: $5,000
Internal Medicine $5,000
Tapan Mehta, Md, MD
Internal Medicine — Payments: $1,215
Internal Medicine $1,215